Rationale, design, and methods for a Coreg (Carvedilol) Heart Failure Registry (COHERE)

Journal of Cardiac Failure

Volumn 6, Issue 3, 2000, Pages 264-271

  Franciosa, Joseph A ^{a,b,c,d,e,f,g,h}   Abraham, William T ^{a,b,c,d,e,f,g,h}   Fowler, Michael ^{a,b,c,d,e,f,g,h}   Gilbert, Edward M ^{a,b,c,d,e,f,g,h}   Greenberg, Barry ^{a,b,c,d,e,f,g,h}   Massie, Barry M ^{a,b,c,d,e,f,g,h}   Chen, Tony ^{a,b,c,d,e,f,g,h}   Lukas, Mary Ann ^{a,b,c,d,e,f,g,h}   Nelson, Jeanenne J ^{a,b,c,d,e,f,g,h}  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g GLAXOSMITHKLINE   (United Kingdom)

^h IQVIA   (United States)

Author keywords

Clinical trials; Neurohormones; Sympathetic blockade; blockers

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COMMUNITY CARE; HEART FAILURE; HUMAN; METHODOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; TREATMENT OUTCOME;

EID: 0033852460     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2000.9675     Document Type: Article

References (18)

1. Congestive heart failure symptoms in patients with preserved left ventricular systolic function: Analysis of the CASS registry
2. Acute myocardial infarction: One year follow-up of 1138 cases from the Perth Community Coronary register
3. Studies of Left Ventricular Dysfunction (SOLVD) registry: Rationale, design, methods and description of baseline characteristics
4. The relationship between clinical trials and clinical practice: The risks of underestimating its complexity
5. Run-in periods in randomized trials. Implications for the application of results in clinical practice
6. Commentary on the use of run-in periods in clinical trials
7. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States data from the National Registry of Myocardial Infarction 2
8. Congestive heart failure in the community. A study of all incident cases in Olmsted County, Minnesota, in 1991
9. Heart failure in the community
10. Consensus recommendations for the management of chronic heart failure
11. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
12. When to base clinical policies on observational versus randomized trial data
13. Linking automated databases for research in managed care settings
14. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry
15. Where are all the women with heart failure?
16. Safety and effectiveness data: Will children gain access?
17. β-blocker therapy in young children with congestive heart failure under consideration for heart transplantation
18. Effect of betablockade on mortality among high-risk and low-risk patients after myocardial infarction